Hansa Biopharma AB
OTC:HNSBF

Watchlist Manager
Hansa Biopharma AB Logo
Hansa Biopharma AB
OTC:HNSBF
Watchlist
Price: 2.91 USD Market Closed
Market Cap: 317.7m USD

Intrinsic Value

The intrinsic value of one HNSBF stock under the Base Case scenario is hidden USD. Compared to the current market price of 2.91 USD, Hansa Biopharma AB is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

HNSBF Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Hansa Biopharma AB

Intrinsic Value History
Dive into the past to invest in the future

HNSBF looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if HNSBF is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about HNSBF?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is HNSBF valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Hansa Biopharma AB.

Explain Valuation
Compare HNSBF to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HNSA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hansa Biopharma AB

Current Assets 464.1m
Cash & Short-Term Investments 252.1m
Receivables 208.5m
Other Current Assets 3.5m
Non-Current Assets 277m
PP&E 11.5m
Intangibles 265.4m
Current Liabilities 419.7m
Accrued Liabilities 126.8m
Other Current Liabilities 292.9m
Non-Current Liabilities 882.2m
Long-Term Debt 775.7m
Other Non-Current Liabilities 106.5m
Efficiency

Free Cash Flow Analysis
Hansa Biopharma AB

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hansa Biopharma AB

Revenue
178.6m SEK
Cost of Revenue
-72.4m SEK
Gross Profit
106.2m SEK
Operating Expenses
-652.2m SEK
Operating Income
-546m SEK
Other Expenses
-95.2m SEK
Net Income
-641.1m SEK
Fundamental Scores

HNSBF Profitability Score
Profitability Due Diligence

Hansa Biopharma AB's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Hansa Biopharma AB's profitability score is hidden . The higher the profitability score, the more profitable the company is.

HNSBF Solvency Score
Solvency Due Diligence

Hansa Biopharma AB's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
hidden
Solvency
Score

Hansa Biopharma AB's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HNSBF Price Targets Summary
Hansa Biopharma AB

Wall Street analysts forecast HNSBF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HNSBF is 7.17 USD with a low forecast of 3 USD and a high forecast of 10.49 USD.

Lowest
Price Target
3 USD
3% Upside
Average
Price Target
7.17 USD
146% Upside
Highest
Price Target
10.49 USD
260% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Hansa Biopharma AB
does not pay dividends
Shareholder Yield

Current shareholder yield for HNSA is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one HNSBF stock?

The intrinsic value of one HNSBF stock under the Base Case scenario is hidden USD.

Is HNSBF stock undervalued or overvalued?

Compared to the current market price of 2.91 USD, Hansa Biopharma AB is hidden .

Back to Top